<DOC>
	<DOCNO>NCT00549159</DOCNO>
	<brief_summary>The purpose study compare treatment success study group .</brief_summary>
	<brief_title>CavatermTM v TCRE Women With DUB</brief_title>
	<detailed_description>Study success define reduction uterine bleeding evaluate number patient obtain amenorrhea , hypomenorrhea eumenorrhea quantify PBLAC &lt; 75 .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<criteria>Willingness adequate mental capacity sign write , informed consent Willingness adhere study plan regard control visit record PBLAC &gt; 30 year old Premenopausal determine FSH ≤30 Agree use hormonal contraception intervention bleed study Suitable local and/or general anesthesia A minimum PBLAC score ≥ 150 three month prior study enrollment ; OR PBLAC score 150 one month woman 1 ) least 3 ( document ) prior month fail medical therapy ; 2 ) contraindication medical therapy ; 3 ) refuse medical therapy Uterine cavity sound measurement ≥ 4 cm ≤ 10 cm . Presence bacteriaemia , sepsis , active systemic infection Active pelvic inflammatory disease Clotting defect bleed disorder Unwillingness use nonhormonal birth control postablation Desire future fertility Abnormal cavity confirm hysteroscopy , transvaginal ultrasound HSG e.g . large fibroid , septum etc . Small submucosal fibroid define &lt; 2 cm context consider abnormal . Any condition lead possible uterine wall weakness total wall thickness &lt; 15 mm e.g . c.section , postmyomectomy scar etc . In case uniform uterine wall wall thickness fundus measure . Premalignant malignant uterine condition within last five year confirm histology Pregnancy Cervical length &gt; 6 cm . Uterine cavity &gt; 30 ml define balloon fill 30ml glucose solution without reach target pressure 240 mmHg . ( These patient may still treat planned withdrawn study data analyse separately . The patient record screen failure ) . Previous ablation subtotal hysterectomy</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>menorrhagia</keyword>
	<keyword>dysfunctional uterine bleeding</keyword>
	<keyword>endometrial ablation</keyword>
</DOC>